WHO ICTRP trial

Effect of tranexamic acid on delirium after hip and knee arthroplasty in elderly…

ChiCTR2500095120 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting

Key facts

Trial ID ChiCTR2500095120
Public title Effect of tranexamic acid on delirium after hip and knee arthroplasty in elderly patients And the relationship between Tau-PT217 and postoperative delirium
Scientific title Effect of tranexamic acid on delirium after hip and knee arthroplasty in elderly patients And the relationship between Tau-PT217 and postoperative delirium
Primary sponsor Tai 'an Central Hospital (Tai 'an Central Hospital affiliated to Qingdao University) Taishan Medical Center)
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Not Recruiting
Study type Interventional study
Phase 4
Countries China
Conditions Hip and knee replacement
Interventions Tranexamic acid group:Intravenous tranexamic acid 1g was given 30min before operation;control group:Isovolumic saline
Registration date Jan 2, 2025
Target size Tranexamic acid group:100;control group:100
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations